Bambusa Therapeutics hits 52-week high in regular trading

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Bambusa Therapeutics (BBTX.US) climbed nearly 4% during regular trading to $17.65, hitting a 52-week high intraday.

The company recently completed an oversubscribed initial public offering at the midpoint price of $16 per share, selling 10.6 million shares to raise $169 million.

Based on public media reports. AI-generated; not investment advice.

Source: Market Movers The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.